Join to View Full Profile
Chs 66 124 Leconte Ave# 10833Los Angeles, CA 90095
Phone+1 310-206-6766
Dr. Daskivich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 2008 - 2012- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2006 - 2008
Harvard Medical SchoolClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2025
American Board of Urology Urology
Clinical Trials
- Using Fitbit to Monitor Ambulation in Patients After Surgery. Start of enrollment: 2016 May 01
- High Resolution PET-MRI Before Prostate Cancer HIFU Start of enrollment: 2017 Dec 07
- Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies Start of enrollment: 2021 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer.Le Zhang, Pai-Chi Teng, Karen A Cavassani, Jasmine Wang, Catherine Grasso
Clinical Cancer Research. 2025-03-10 - 2 citationsVariation in communication of side effects in prostate cancer treatment consultations.Timothy J Daskivich, Aurash Naser-Tavakolian, Rebecca Gale, Michael Luu, Nadine Friedrich
Prostate Cancer and Prostatic Diseases. 2025-03-01 - Potential miscommunication of risk in American College of Radiology Prostate Imaging and Data System (PIRADS) scores.Jeremiah R Dallmer, Brennan Spiegel, Stephen J Freedland, Rola Saouaf, Paige Kuhlmann
Prostate Cancer and Prostatic Diseases. 2025-03-01
Journal Articles
- Effect of Androgen Deprivation on Long-Term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or UnfavorableTimothy Daskivich, MD, JAMA Network Open
Press Mentions
VA Study Asks: Has Active Surveillance Solved the Problem of Overtreatment?January 28th, 2025- Prostate Cancer: Has Active Surveillance Solved the Problem of Overtreatment?November 18th, 2024
- Overtreatment of Prostate Cancer Increasing in Men with Short Life ExpectancyNovember 14th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
